Total Payments
$3,267
2024 Payments
$1,848
Companies
17
Transactions
156
Medicare Patients
156
Medicare Billing
$10,179
Payment Breakdown by Category
Food & Beverage$3,267 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,267 | 156 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $507.35 | 28 | $0 (2024) |
| Supernus Pharmaceuticals, Inc. | $450.61 | 13 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $445.98 | 17 | $0 (2024) |
| Alkermes, Inc. | $421.73 | 25 | $0 (2024) |
| Indivior Inc. | $318.72 | 13 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $313.27 | 17 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $288.35 | 17 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $100.83 | 5 | $0 (2024) |
| Lundbeck LLC | $85.01 | 5 | $0 (2024) |
| Vanda Pharmaceuticals Inc. | $70.78 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,848 | 81 | Supernus Pharmaceuticals, Inc. ($401.89) |
| 2023 | $1,233 | 64 | Neurocrine Biosciences, Inc. ($281.64) |
| 2022 | $71.28 | 4 | Janssen Pharmaceuticals, Inc ($29.42) |
| 2021 | $114.12 | 7 | Alkermes, Inc. ($37.02) |
All Payment Transactions
156 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $17.03 | General |
| Category: PSYCHIATRY | ||||||
| 12/10/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug) | Food and Beverage | In-kind items and services | $17.69 | General |
| Category: PSYCHIATRY | ||||||
| 12/05/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.39 | General |
| Category: NEUROSCIENCE | ||||||
| 12/04/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $13.44 | General |
| Category: Neuroscience | ||||||
| 12/03/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $21.43 | General |
| Category: CNS | ||||||
| 11/26/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $32.46 | General |
| Category: Neuropsychiatry | ||||||
| 11/21/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $16.04 | General |
| Category: Neuroscience | ||||||
| 11/20/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug), ABILIFY MAINTENA | Food and Beverage | In-kind items and services | $15.10 | General |
| Category: PSYCHIATRY | ||||||
| 11/19/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $27.69 | General |
| Category: PSYCHIATRY | ||||||
| 11/13/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $13.81 | General |
| Category: PSYCHIATRY | ||||||
| 11/07/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $19.47 | General |
| Category: CNS | ||||||
| 11/06/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $19.41 | General |
| Category: Psychology/Psychiatric | ||||||
| 10/31/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $18.91 | General |
| Category: Neuropsychiatry | ||||||
| 10/30/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $13.47 | General |
| Category: Central Nervous System | ||||||
| 10/29/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $8.56 | General |
| Category: PSYCHIATRY | ||||||
| 10/24/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.56 | General |
| Category: NEUROSCIENCE | ||||||
| 10/17/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $19.91 | General |
| Category: PSYCHIATRY | ||||||
| 10/10/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $15.02 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 10/09/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $16.20 | General |
| Category: Neuroscience | ||||||
| 10/08/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $28.47 | General |
| Category: CNS | ||||||
| 10/03/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $19.88 | General |
| Category: Psychology/Psychiatric | ||||||
| 09/25/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $23.67 | General |
| Category: Neuropsychiatry | ||||||
| 09/05/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.56 | General |
| Category: NEUROSCIENCE | ||||||
| 08/28/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $16.90 | General |
| Category: Psychology/Psychiatric | ||||||
| 08/27/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $3.91 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 4 | 75 | 80 | $10,296 | $4,441 |
| 2020 | 3 | 81 | 93 | $13,233 | $5,738 |
Total Patients
156
Total Services
173
Medicare Billing
$10,179
Procedure Codes
7
All Medicare Procedures & Services
7 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90791 | Psychiatric diagnostic evaluation | Facility | 2021 | 16 | 18 | $1,951 | $1,474 | 75.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 28 | 29 | $3,915 | $1,389 | 35.5% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 16 | 17 | $3,230 | $1,169 | 36.2% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 15 | 16 | $1,200 | $409.28 | 34.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 41 | 51 | $6,885 | $2,483 | 36.1% |
| 90791 | Psychiatric diagnostic evaluation | Facility | 2020 | 20 | 20 | $2,168 | $1,717 | 79.2% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 20 | 22 | $4,180 | $1,538 | 36.8% |
About Robbin Mulina
Robbin Mulina is a Psychiatric/Mental Health healthcare provider based in Houma, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/09/2016. The National Provider Identifier (NPI) number assigned to this provider is 1992154900.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Robbin Mulina has received a total of $3,267 in payments from pharmaceutical and medical device companies, with $1,848 received in 2024. These payments were reported across 156 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($3,267).
As a Medicare-enrolled provider, Mulina has provided services to 156 Medicare beneficiaries, totaling 173 services with total Medicare billing of $10,179. Data is available for 2 years (2020–2021), covering 7 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatric/Mental Health
- Location Houma, LA
- Active Since 06/09/2016
- Last Updated 06/09/2016
- Taxonomy Code 363LP0808X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1992154900
Products in Payments
- VRAYLAR (Drug) $507.35
- INGREZZA (Drug) $445.98
- Qelbree (Drug) $401.89
- ARISTADA (Drug) $360.13
- PERSERIS (Drug) $309.90
- INVEGA SUSTENNA (Drug) $240.91
- REXULTI (Drug) $188.26
- ABILIFY MAINTENA (Drug) $110.21
- ABILIFY ASIMTUFII (Drug) $99.81
- UZEDY (Drug) $87.36
- CAPLYTA (Drug) $86.18
- Azstarys (Drug) $63.49
- Auvelity (Drug) $56.19
- QELBREE (Drug) $48.72
- SPRAVATO (Drug) $47.44
- Vivitrol (Drug) $42.78
- HETLIOZ (Drug) $37.75
- FANAPT (Drug) $33.03
- LATUDA (Drug) $22.96
- VIVITROL (Drug) $18.82
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatric/Mental Health Doctors in Houma
Dr. Amanda Eymard, Dns, Aprn, Pmhnp-Bc, DNS, APRN, PMHNP-BC
Psychiatric/Mental Health — Payments: $452,601
Psychiatric/Mental Health $452,601
Timothy Pellegrin, Pmhnp-Bc, PMHNP-BC
Psychiatric/Mental Health — Payments: $144,953
Psychiatric/Mental Health $144,953
Mr. Harry Brown, Aprn, APRN
Psychiatric/Mental Health — Payments: $7,345
Psychiatric/Mental Health $7,345
Mrs. Bethany Legendre, Pmhnp-Bc, PMHNP-BC
Psychiatric/Mental Health — Payments: $3,111
Psychiatric/Mental Health $3,111
Richard Bergeron, Pmhnp, Msn, PMHNP, MSN
Psychiatric/Mental Health — Payments: $3,006
Psychiatric/Mental Health $3,006
Dustin Hebert, Pmhnp, PMHNP
Psychiatric/Mental Health — Payments: $2,981
Psychiatric/Mental Health $2,981